These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30684512)
1. Pharmacokinetics and pharmacodynamics of liposomal chemophototherapy with short drug-light intervals. Luo D; Carter KA; Molins EAG; Straubinger NL; Geng J; Shao S; Jusko WJ; Straubinger RM; Lovell JF J Control Release; 2019 Mar; 297():39-47. PubMed ID: 30684512 [TBL] [Abstract][Full Text] [Related]
2. Short Drug-Light Intervals Improve Liposomal Chemophototherapy in Mice Bearing MIA PaCa-2 Xenografts. Luo D; Carter KA; Geng J; He X; Lovell JF Mol Pharm; 2018 Sep; 15(9):3682-3689. PubMed ID: 29608312 [TBL] [Abstract][Full Text] [Related]
3. PK/PD model for liposomal chemophototherapy. Park K J Control Release; 2019 Mar; 297():102. PubMed ID: 30827365 [No Abstract] [Full Text] [Related]
4. Vessel-Targeted Chemophototherapy with Cationic Porphyrin-Phospholipid Liposomes. Luo D; Geng J; Li N; Carter KA; Shao S; Atilla-Gokcumen GE; Lovell JF Mol Cancer Ther; 2017 Nov; 16(11):2452-2461. PubMed ID: 28729400 [TBL] [Abstract][Full Text] [Related]
5. Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Luo D; Carter KA; Razi A; Geng J; Shao S; Giraldo D; Sunar U; Ortega J; Lovell JF Biomaterials; 2016 Jan; 75():193-202. PubMed ID: 26513413 [TBL] [Abstract][Full Text] [Related]
6. Blood Interactions, Pharmacokinetics, and Depth-Dependent Ablation of Rat Mammary Tumors with Photoactivatable, Liposomal Doxorubicin. Carter KA; Luo D; Geng J; Stern ST; Lovell JF Mol Cancer Ther; 2019 Mar; 18(3):592-601. PubMed ID: 30587558 [TBL] [Abstract][Full Text] [Related]
7. Metal Chelation Modulates Phototherapeutic Properties of Mitoxantrone-Loaded Porphyrin-Phospholipid Liposomes. Carter KA; Wang S; Geng J; Luo D; Shao S; Lovell JF Mol Pharm; 2016 Feb; 13(2):420-7. PubMed ID: 26691879 [TBL] [Abstract][Full Text] [Related]
8. Intrabilayer Luo D; Goel S; Liu HJ; Carter KA; Jiang D; Geng J; Kutyreff CJ; Engle JW; Huang WC; Shao S; Fang C; Cai W; Lovell JF ACS Nano; 2017 Dec; 11(12):12482-12491. PubMed ID: 29195037 [TBL] [Abstract][Full Text] [Related]
9. Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids. Luo D; Li N; Carter KA; Lin C; Geng J; Shao S; Huang WC; Qin Y; Atilla-Gokcumen GE; Lovell JF Small; 2016 Jun; 12(22):3039-47. PubMed ID: 27121003 [TBL] [Abstract][Full Text] [Related]
10. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect. Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin. Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491 [TBL] [Abstract][Full Text] [Related]
12. Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment. Peng PC; Hong RL; Tsai YJ; Li PT; Tsai T; Chen CT Lasers Surg Med; 2015 Jan; 47(1):77-87. PubMed ID: 25559348 [TBL] [Abstract][Full Text] [Related]
13. Photosensitizer-Doped and Plasma Membrane-Responsive Liposomes for Nuclear Drug Delivery and Multidrug Resistance Reversal. Zhu YX; Jia HR; Duan QY; Liu X; Yang J; Liu Y; Wu FG ACS Appl Mater Interfaces; 2020 Aug; 12(33):36882-36894. PubMed ID: 32666795 [TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs. Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779 [TBL] [Abstract][Full Text] [Related]
15. Porphyrin-phospholipid liposomes with tunable leakiness. Luo D; Carter KA; Razi A; Geng J; Shao S; Lin C; Ortega J; Lovell JF J Control Release; 2015 Dec; 220(Pt A):484-494. PubMed ID: 26578438 [TBL] [Abstract][Full Text] [Related]
17. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model. Moosavian SA; Abnous K; Badiee A; Jaafari MR Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819 [TBL] [Abstract][Full Text] [Related]
18. A Novel Long-circulating DOX Liposome: Formulation and Pharmacokinetics Studies. Xiao P; Zhao J; Huang Y; Jin R; Tang Z; Wang P; Song X; Zhu H; Yang Z; Yu N Pharm Nanotechnol; 2020; 8(5):391-398. PubMed ID: 32787769 [TBL] [Abstract][Full Text] [Related]